Home › Funds › Avoro Capital Advisors LLC › VERA
Avoro Capital Advisors LLC position in VERA
VERA THERAPEUTICS INC · Health Care
Avoro Capital Advisors LLC reported holding 5,635,000 shares of VERA (VERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$182.0M, representing 1.88% of its reported portfolio and ranking #13 among its reported holdings. Avoro Capital Advisors LLC has disclosed VERA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's VERA position evolved
Avoro Capital Advisors LLC first disclosed a stake in VERA in Q1 2024 at 5,265,000 shares (US$227.0M). The position peaked in Q4 2025 at 5,888,888 shares, worth US$298.2M. Across 11 filings, Avoro Capital Advisors LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 5,635,000 shares valued at US$182.0M — a reduction of -88,888 shares quarter over quarter.. Notable position changes include a 30% increase in Q4 2024 (shares fell 43% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 5.26M | $227.03M | New |
| Q2 2024 | 4.31M | $155.92M | Reduce |
| Q3 2024 | 4.31M | $190.48M | Hold |
| Q4 2024 | 5.61M | $237.25M | Add |
| Q1 2025 | 5.70M | $136.96M | Add |
| Q2 2025 | 6.30M | $148.43M | Add |
| Q3 2025 | 6.21M | $180.46M | Reduce |
| Q4 2025 | 5.89M | $298.21M | Reduce |
| Q1 2026 | 5.89M | $236.91M | Hold |
| Q2 2026 | 5.72M | $245.61M | Reduce |
| Q3 2026 | 5.63M | $181.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VERA and 13F data
VERA (VERA THERAPEUTICS INC) is a Health Care company. 30 other funds we track also report a position in VERA — the largest reported positions include Deep Track Capital, LP (US$226.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M), Kynam Capital Management, LP (US$96.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VERA
- Deep Track Capital, LP 7.00M sh · $226.03M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.92M sh · $168.05M · Q2 2026
- Kynam Capital Management, LP 3.00M sh · $96.87M · Q3 2026
- Sofinnova Investments, Inc. 2.79M sh · $90.22M · Q3 2026
- Eversept Partners, LP 2.36M sh · $76.27M · Q3 2026
- Bellevue Group AG 1.71M sh · $73.41M · Q2 2026
- Integral Health Asset Management, LLC 1.50M sh · $32.29M · Q3 2026
- GREAT POINT PARTNERS LLC 600.84K sh · $25.78M · Q2 2026
- BRAIDWELL LP 564.72K sh · $24.23M · Q2 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held VERA?
Avoro Capital Advisors LLC has disclosed VERA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Avoro Capital Advisors LLC's current position in VERA?
As of Q3 2026, Avoro Capital Advisors LLC holds 5.63M shares of VERA (VERA THERAPEUTICS INC), valued at $181.95M, representing 1.88% of its reported portfolio and ranking #13.
Has Avoro Capital Advisors LLC been buying or selling VERA?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC reduced its position in VERA. The position peaked in Q4 2025 at 5.89M shares.
Which other funds hold VERA?
Other major institutional holders of VERA include Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Kynam Capital Management, LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.